Treatment of Self-Injurious Behavior in Individuals With Prader-Willi Syndrome
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Prader-Willi syndrome (PWS) is a genetic disorder usually caused by the deletion of a
specific gene. One of the symptoms of PWS is self-injurious behavior (SIB); a common form of
SIB in PWS patients is skin picking. The injury may be severe enough to require frequent
medical attention. This trial will evaluate SIB in individuals with PWS and will test the
effectiveness of the drug topiramate to control SIB.
Phase:
N/A
Details
Lead Sponsor:
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)